Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SI-BONE, Inc. Director's Dealing 2023

Nov 21, 2023

32647_dirs_2023-11-20_88928fa7-04eb-412f-8e5b-a423903d302e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SI-BONE, Inc. (SIBN)
CIK: 0001459839
Period of Report: 2023-11-16

Reporting Person: DUNN JEFFREY W (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-11-16 Common Stock S 1956.00 $17.708 Disposed 50727.00 Direct
2023-11-16 Common Stock S 4495.00 $17.6833 Disposed 46232.00 Direct
2023-11-16 Common Stock S 1514.00 $17.6849 Disposed 44718.00 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 83885.00 Indirect

Footnotes

F1: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in
connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2: This transaction was executed in multiple trades at prices ranging from $17.18 USD to $17.86 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the
Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the
range set forth in this footnote.

F3: This transaction was executed in multiple trades at prices ranging from $17.18 USD to $17.87 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the
Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the
range set forth in this footnote.

F4: Includes 36,236 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit
represents a contingent right to receive one share of the Issuer's common stock.

F5: Shares held by The Jeffrey W. Dunn Living Trust Dated May 17, 2012.